Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 6/20 | 0.52 |
| ▸ | ALPI | P09923 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | XIAP | P98170 | 1/20 | 0.52 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.43 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.43 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.43 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | NOS3 | P29474 | 1/20 | 0.39 |
| ▸ | NOS1 | P29475 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 1/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | ANPEP | P15144 | 1/20 | 0.38 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.38 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.38 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dl-Phenylalanine SCHEMBL22559546 | 0.98 | SLC7A5 (0.50) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine SCHEMBL8904329 | 0.91 | SLC7A5 (0.56) | SLC7A5ALPIPKMPTGS1XIAP | |
| Histidine SCHEMBL6426902 | 0.91 | SLC7A5 (0.40) | SLC7A5ALPIPKMPTGS1XIAP | |
| Histidine SCHEMBL668807 | 0.91 | SLC7A5 (0.40) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL1007041 | 0.91 | SLC7A5 (0.63) | SLC7A5ALPIPKMPTGS1XIAP | |
| Histidine SCHEMBL28805947 | 0.91 | SLC7A5 (0.40) | SLC7A5ALPIPKMPTGS1XIAP | |
| Histidine SCHEMBL6426901 | 0.91 | SLC7A5 (0.40) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine SCHEMBL638657 | 0.91 | SLC7A5 (0.63) | SLC7A5ALPIPKMPTGS1XIAP | |
| Threonine SCHEMBL9114670 | 0.91 | ALPI (0.42) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL23580654 | 0.91 | SLC7A5 (0.43) | SLC7A5ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6339150-B1 | A GENETICALLY MUTATED VIRICIDE GENE; THERAPY FOR LYMPHADENOPATHY ASSOCIATED VIRUS | DUKE UNIVERSITY | 2002-01-15 | — | — | US | disclosed |
| EP-0406557-B1 | Multivalent repressor of gene function | NOVARTIS AG (CH) | 2001-10-17 | — | — | EP | disclosed |
| US-6287809-B1 | PROTEIN WHICH REPRESSES PHENOTYPIC EXPRESSION OF WILD-TYPE REX GENE OF HUMAN T-CELL LEUKEMIA/LYMPHOMA VIRUS-1 OR -2 AND/OR WILD-TYPE REV GENE OF HUMAN IMMUNODEFICIENCY VIRUS-1; VIRICIDES; PROPHYLAXIS | NOVARTIS AG (CH) | 2001-09-11 | — | — | US | disclosed |
| US-6251675-B1 | MODIFYING CELL BY DELIVERING MUTANT REV GENE HAVING MUTATION FROM AMINO ACID POSITION 68 TO 90 OF THE WILD-TYPE PROTEIN; INTRACELLULAR IMMUNIZATION | DUKE UNIVERSITY | 2001-06-26 | — | — | US | disclosed |
| US-6162898-A | Mutant Rev transdominant repressors of HIV replication | DUKE UNIVERSITY (US) | 2000-12-19 | — | — | US | disclosed |
| US-5871958-A | VIRICIDES; GENETIC ENGINEERING | DUKE UNIVERSITY (US) | 1999-02-16 | — | — | US | disclosed |
| EP-0644937-A4 | THERAPEUTIC AND DIAGNOSTIC METHODS BASED ON NEUROTROPHIN-4 EXPRESSION. | — | 1995-05-03 | — | — | EP | disclosed |
| EP-0587806-A4 | THERAPEUTIC AND DIAGNOSTIC METHODS BASED ON NEUROTROPHIN-4 EXPRESSION. | REGENERON PHARMA (US) | 1995-04-26 | — | — | EP | disclosed |
| EP-0644937-A1 | THERAPEUTIC AND DIAGNOSTIC METHODS BASED ON NEUROTROPHIN-4 EXPRESSION | REGENERON PHARMACEUTICALS, INC. (US) | 1995-03-29 | — | — | EP | disclosed |
| EP-0587806-A1 | THERAPEUTIC AND DIAGNOSTIC METHODS BASED ON NEUROTROPHIN-4 EXPRESSION | REGENERON PHARMACEUTICALS, INC. (US) | 1994-03-23 | — | — | EP | disclosed |
| WO-1993025684-A1 | THERAPEUTIC AND DIAGNOSTIC METHODS BASED ON NEUROTROPHIN-4 EXPRESSION | REGENERON PHARMACEUTICALS, INC. (US) | 1993-12-23 | — | — | WO | disclosed |
| WO-1992020365-A1 | THERAPEUTIC AND DIAGNOSTIC METHODS BASED ON NEUROTROPHIN-4 EXPRESSION | REGENERON PHARMACEUTICALS, INC. (US) | 1992-11-26 | — | — | WO | disclosed |
| EP-0406557-A2 | Multivalent repressor of gene function | SANDOZ LTD. (CH) | 1991-01-09 | — | — | EP | disclosed |
| WO-1990014427-A2 | MULTIVALENT REPRESSOR OF GENE FUNCTION | SANDOZ LTD (CH) | 1990-11-29 | — | — | WO | disclosed |